Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Sensyne Health announced Thursday, Oct. 10, that it has joined Bayer’s newest innovation hub, LifeHub UK, and will work toward developing solutions for automated image evaluation.
A team of researchers from West Virginia and Arkansas are beginning a four-year project aimed at using AI to improve the treatment of cardiovascular disease and cut healthcare costs.
AI can improve CT findings and play a key role in the evaluation of hypovascular hepatic metastases, according to a new study published in Radiology: Artificial Intelligence.
Insilico Medicine, a Hong Kong-based AI company, has announced a new collaboration with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CTFH) aimed at improving care for breast cancer patients.
A convolutional neural network (CNN) could assist radiologists with the detection and segmentation of suspicious findings on prostate MRI scans, according to a new study published in Radiology.
Northeastern University in Boston has announced the launch of a new research hub focused on ensuring AI systems help rather than replace humans working in healthcare, cybersecurity and sustainability.
Machine learning can help electrophysiologists or other heart specialists decide whether a patient is a good candidate for a pacemaker or implantable cardioverter defibrillator, according to a study published Oct. 3 in PLOS One.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
